UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF) compared with placebo1 Holistic benefit: secondary endpoints showed significant...
LONGi Chairman Zhong Baoshen Spoke at Davos 2025 Conference: Global Cooperation Will Accelerate the Adoption of Photovoltaic Technology, Empowering Humanity to Achieve Energy Equity
DAVOS, Switzerland, Jan. 26, 2025 /PRNewswire/ -- On the morning of January 22, 2025, Zhong Baoshen, Chairman of LONGi, attended the "WEF Electricity Industry CEOs Meeting" with Christian Bruch, President and CEO of Siemens Energy; Gurdeep Singh,...